Liminatus Pharma Inc (NASDAQ: LIMN) is -10.78% lower on its value in year-to-date trading and has touched a low of $4.40 and a high of $33.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LIMN stock was last observed hovering at around $8.81 in the last trading session, with the day’s gains setting it 0.21%.
Currently trading at $9.02, the stock is -45.55% and -14.14% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 2.38% at the moment leaves the stock -15.69% off its SMA200. LIMN registered -19.61% loss for a year compared to 6-month loss of -15.15%. The firm has a 50-day simple moving average (SMA 50) of $11.125372 and a 200-day simple moving average (SMA200) of $11.125372.
The stock witnessed a 70.19% gain in the last 1 month and extending the period to 3 months gives it a -17.55%, and is -45.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 34.47% over the week and 46.78% over the month.
Liminatus Pharma Inc (LIMN) has around 3 employees, a market worth around $234.65M and $0.00M in sales. Distance from 52-week low is 105.00% and -73.20% from its 52-week high.
The shares outstanding are 26.01M, and float is at 3.10M with Short Float at 1.56%.
